Search

everythinglearnresearchcommunity

for

Search:↓

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Hydrocortisone 17-butyrate 21-propionate ointment caused reversible side effects like skin issues, weight gain, and organ changes in dogs.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.